Breath Diagnostics, Inc.and Mayo Clinic Laboratories have announced a collaboration to develop clinical diagnostic tests that use patient breath samples to identify individual biomarkers that can predict a spectrum of diseases. The two organizations will initially focus on a test that can detect lung cancer. Read full article here.
Interview with Dr. Victor van Berkel
Interview with Dr. Michael Bousamra
UofL Today Introduces Breath Diagnostics’s Technology
University of Louisville teams up with company to help lung cancer diagnosis
Lung Cancer Breath ‘Signature’ Presents Promise for Earlier Diagnosis

See the latest articles in The Annals of Thoracic Surgery. Founded in 1964, The Society of Thoracic Surgeons is a not-for-profit organization representing more than 7,200 cardiothoracic surgeons, researchers, and allied health care professionals worldwide who are dedicated to ensuring the best possible outcomes for surgeries of the heart, lung, and esophagus, as well as […]
Breath Diagnostics takes top prize at MedCity INVEST

In April on the heels of SXSW, Rick Rummel took the top prize at the MedCity INVEST pitch competition. MedCity Invest (fka the MidAmerican Healthcare Venture Forum) is the premier national healthcare investing conference. It has been held annually for more than a decade. The Medcity team called Breath Diagnostics Inc. and three of its […]
The Importance of Technology in Healthcare
With the SXSW Interactive event SXSW Accelerator Pitch Event quickly approaching – March 11th through March 15th the SXSW website published a great piece on how today’s technology is much different than in years past in regards to cancer detection and treatment. Visit the SXSW website to read the full story.